Stockreport

Inhibikase Announces Expansion of Senior Leadership Team

Inhibikase Therapeutics, Inc.  (IKT) 
PDF --- Chris Cabell, MD MHS FACC Appointed President and Head of Research & Development --- --- John Adams, PhD Appointed Chief Scientific Officer --- --- Vince Auren [Read more]